Table 3.
Pathoclinical features in the cases of endotremial cancer with hypercalcemia.
| Author | Pathology | Serum Ca2+ level | Treatment accepted | Outcome |
|---|---|---|---|---|
| Visnyei et al. 14 | ECΩ | 3 mmol/L | Bisphosphonate | Discharged |
| Nehru et al. 15 | SS& | 4.8 mmol/L | Chemotherapy+radiation | DOD# |
| Sachmech et al. 16 | PSCΔ | 3.2 mmol/L | Surgery+chemotherapy | Discharged |
| Mitchell et al. 17 | EEA$ | 3.7 mmol/L | Bisphosphonate+calcitonin | DOD |
| Current report | NCФ | 3.7 mmol/L | Bisphosphonate+calcitonin | DOD |
ECΩ: endometrioid carcinoma; SS&: stromal sarcoma; DOD#: dead of disease; PSCΔ: papillary serous carcinoma; EEA$: endometrioid endometrial adenocarcinoma; NCФ: neuroendocrine carcinoma.